Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: No shots required · pill and pen. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
Ro's ad uses scale to make its point. The pill fills most of the frame while the pen sits small underneath, so the visual hierarchy says which option the ad is about before anyone reads. The headline names the injection worry directly and attributes the comparison to Ro's claim. It ran on Meta from August 18, 2026, and it's a simple layout another brand could adapt for any new format that replaces an old one.
The ad relies on the claim alone, with nothing that backs it up or tells the viewer what to do next beyond the generic button. There's no price, no member voice and no sense of how easy the switch is. If you make one like this, keep the big-versus-small composition and add one specific line under the headline (how often you take it, or what the first step is), so the viewer has something concrete to act on.
The size contrast shows which format the ad is promoting and which one it replaces.
It speaks to the injection objection directly, framed as Ro's claim.
The landing page is Ro's quiz entry, which sits at the strongest rung of the landing-page ladder. Its first question lists GLP-1 pill as an answer, so someone who tapped for the no-shots option can choose it right away, and the learn-about-both answer covers anyone still comparing. The page doesn't repeat the no-shots message or show the pill, relying instead on the Serena Williams hero. Echoing the ad's line next to the pill answer would make the match unmistakable. It's one of 71 ads in the Fluid library landing here.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.